Citations

Citations to this article as recorded by  

• Fasting glucose variability and risk of dementia in Parkinson’s disease: a 9-year longitudinal follow-up study of a nationwide cohort
  Sung Hoon Kang, Yunjin Choi, Su Jin Chung, Seok-Joo Moon, Chi Kyung Kim, Ji Hyun Kim, Kyungmi Oh, Joon Shik Yoon, Sang Won Seo, Geum Joon Cho, Seong-Beom Koh
  Frontiers in Aging Neuroscience.2024;[Epub]     CrossRef
• Effects of a Diabetic Microenvironment on Neurodegeneration: Special Focus on Neurological Cells
  Vishal Chavda, Dhananjay Yadav, Snehal Patel, Minseok Song
  Brain Sciences.2024; 14(3): 284.     CrossRef
• The Association of Glucose Variability and Dementia Incidence in Latinx Adults with Type 2 Diabetes: A Retrospective Study
  Heather Cuevas, Elizabeth Muñoz, Divya Nagireddy, Jeeyeon Kim, Grace Ganucheau, Fathia Alomoush
  Clinical Nursing Research.2023; 32(2): 249.     CrossRef
• The effects of long-term cumulative HbA1c exposure on the development and onset time of dementia in the patients with type 2 diabetes mellitus: Hospital based retrospective study (2005–2021)
  Sunyoung Cho, Choon Ok Kim, Bong-soo Cha, Eosu Kim, Chung Mo Nam, Min-Gul Kim, Min Soo Park
  Diabetes Research and Clinical Practice.2023; 201: 110721.     CrossRef
• Physiological Mechanisms Inherent to Diabetes Involved in the Development of Dementia: Alzheimer’s Disease
  Himan Mohamed-Mohamed, Victoria García-Morales, Encarnación María Sánchez Lara, Anabel González-Acedo, Teresa Pardo-Moreno, María Isabel Tovar-Gálvez, Lucía Melguizo-Rodríguez, Juan José Ramos-Rodríguez
  Neurology International.2023; 15(4): 1253.     CrossRef
• Cumulative effect of impaired fasting glucose on the risk of dementia in middle-aged and elderly people: a nationwide cohort study
  Jin Yu, Kyu-Na Lee, Hun-Sung Kim, Kyungdo Han, Seung-Hwan Lee
  Scientific Reports.2023;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Unlocking the Protective Potential of Upper Respiratory Infection Treatment Histories against Alzheimer’s Disease: A Korean Adult Population Study
  Ho Suk Kang, Ji Hee Kim, Joo-Hee Kim, Woo Jin Bang, Hyo Geun Choi, Nan Young Kim, Ha Young Park, Mi Jung Kwon
  Journal of Clinical Medicine.2024; 13(1): 260.     CrossRef
• Hepatopancreatic metabolic disorders and their implications in the development of Alzheimer's disease and vascular dementia
  Francisco I. Pinheiro, Irami Araújo-Filho, Amália C.M. do Rego, Eduardo P. de Azevedo, Ricardo N. Cobucci, Fausto P. Guzen
  Ageing Research Reviews.2024; 96: 102250.     CrossRef
• Amygdala activity and amygdala-hippocampus connectivity: Metabolic diseases, dementia, and neuropsychiatric issues
  Juhyun Song
  Biomedicine & Pharmacotherapy.2023; 162: 114647.     CrossRef
• The effects of long-term cumulative HbA1c exposure on the development and onset time of dementia in the patients with type 2 diabetes mellitus: Hospital based retrospective study (2005–2021)
  Sunyoung Cho, Choon Ok Kim, Bong-soo Cha, Eosu Kim, Chung Mo Nam, Min-Gul Kim, Min Soo Park
  Diabetes Research and Clinical Practice.2023; 201: 110721.     CrossRef
• Association of triglyceride/high-density lipoprotein cholesterol ratio with severe complications of COVID-19
  Yoonkyung Chang, Jimin Jeon, Tae-Jin Song, Jinkwon Kim
  Heliyon.2023; 9(6): e17428.     CrossRef
• Akkermansia muciniphila in neuropsychiatric disorders: friend or foe?
  Wenhui Lei, Yiwen Cheng, Jie Gao, Xia Liu, Li Shao, Qingming Kong, Nengneng Zheng, Zongxin Ling, Weiming Hu
  Frontiers in Cellular and Infection Microbiology.2023;[Epub]     CrossRef
• The Association Between Eye Disease and Incidence of Dementia: Systematic Review and Meta-Analysis
  Jiayi Feng, Cuihong Huang, Lei Liang, Chuang Li, Xiaojie Wang, Jianping Ma, Xinhui Guan, Bin Jiang, Shaofen Huang, Pei Qin
  Journal of the American Medical Directors Association.2023; 24(9): 1363.     CrossRef
• Risk of Neurodegenerative Diseases in Elderly Koreans with an Initial Diagnosis of Type 2 Diabetes: A Nationwide Retrospective Cohort Study
  Hee-Cheol Kim, Ho-Jun Lee, Yang-Tae Kim, Byeong-Churl Jang, Asirvatham Alwin Robert
  Journal of Diabetes Research.2023; 2023: 1.     CrossRef
• Type-2 Diabetes Alters Hippocampal Neural Oscillations and Disrupts Synchrony between the Hippocampus and Cortex
  Gratianne Rabiller, Zachary Ip, Shahram Zarrabian, Hongxia Zhang, Yoshimichi Sato, Azadeh Yazdan-Shahmorad, Jialing Liu
  Aging and disease.2023;[Epub]     CrossRef
• Sarcopenia and diabetes-induced dementia risk
  Mingyang Sun, Zhongyuan Lu, Wan-Ming Chen, Szu-Yuan Wu, Jiaqiang Zhang
  Brain Communications.2023;[Epub]     CrossRef
• Association of periodontitis with microvascular complications of diabetes mellitus: A nationwide cohort study
  Moo-Seok Park, Jimin Jeon, Tae-Jin Song, Jinkwon Kim
  Journal of Diabetes and its Complications.2022; 36(2): 108107.     CrossRef
• Association between oral health and cardiovascular outcomes in patients with hypertension: a nationwide cohort study
  Jinkwon Kim, Hyung Jun Kim, Jimin Jeon, Tae-Jin Song
  Journal of Hypertension.2022; 40(2): 374.     CrossRef
• Diabetic retinopathy and cognitive dysfunction: a systematic review and meta-analysis
  Mei Wu, Fan Mei, Kaiyan Hu, Liyuan Feng, Zhe Wang, Qianqian Gao, Fei Chen, Li Zhao, Xiaohui Li, Bin Ma
  Acta Diabetologica.2022; 59(4): 443.     CrossRef
• Associations between depression and cognition, mild cognitive impairment and dementia in persons with diabetes mellitus: A systematic review and meta-analysis
  Yeng Yan Chow, Milou Verdonschot, Claire T. McEvoy, Geeske Peeters
  Diabetes Research and Clinical Practice.2022; 185: 109227.     CrossRef
• Diabetes Mellitus: A Path to Amnesia, Personality, and Behavior Change
  Rahnuma Ahmad, Kona Chowdhury, Santosh Kumar, Mohammed Irfan, Govindool Reddy, Farhana Akter, Dilshad Jahan, Mainul Haque
  Biology.2022; 11(3): 382.     CrossRef
• Hypothyroidism and Diabetes-Related Dementia: Focused on Neuronal Dysfunction, Insulin Resistance, and Dyslipidemia
  Hee Kyung Kim, Juhyun Song
  International Journal of Molecular Sciences.2022; 23(6): 2982.     CrossRef
• Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer’s Disease: Review and Meta-Analysis
  Athanasia Athanasaki, Konstantinos Melanis, Ioanna Tsantzali, Maria Ioanna Stefanou, Sofia Ntymenou, Sotirios G. Paraskevas, Theodosis Kalamatianos, Eleni Boutati, Vaia Lambadiari, Konstantinos I. Voumvourakis, George Stranjalis, Sotirios Giannopoulos, Ge
  Biomedicines.2022; 10(4): 778.     CrossRef
• Cardiometabolic measures and cognition in early menopause - Analysis of baseline data from a randomized controlled trial
  Lubna Pal, Kelly Morgan, Nanette F. Santoro, JoAnn E. Manson, Hugh S. Taylor, Virginia M. Miller, Eliot A. Brinton, Rogerio Lobo, Genevieve Neal-Perry, Marcelle I. Cedars, S. Mitchell Harman, Taryn T. James, Carey E. Gleason
  Maturitas.2022; 162: 58.     CrossRef
• Dysfunctional Glucose Metabolism in Alzheimer’s Disease Onset and Potential Pharmacological Interventions
  Vijay Kumar, So-Hyeon Kim, Kausik Bishayee
  International Journal of Molecular Sciences.2022; 23(17): 9540.     CrossRef
• Metabolically healthy obesity: it is time to consider its dynamic changes
  Yun Kyung Cho, Chang Hee Jung
  Cardiovascular Prevention and Pharmacotherapy.2022; 4(4): 123.     CrossRef
• Association between cholesterol levels and dementia risk according to the presence of diabetes and statin use: a nationwide cohort study
  You-Bin Lee, Min Young Kim, Kyungdo Han, Bongsung Kim, Jiyun Park, Gyuri Kim, Kyu Yeon Hur, Jae Hyeon Kim, Sang-Man Jin
  Scientific Reports.2022;[Epub]     CrossRef
• The insulin resistance by triglyceride glucose index and risk for dementia: population-based study
  Sangmo Hong, Kyungdo Han, Cheol-Young Park
  Alzheimer's Research & Therapy.2021;[Epub]     CrossRef
• The identification of established modifiable mid-life risk factors for cardiovascular disease which contribute to cognitive decline: Korean Longitudinal Study of Aging (KLoSA)
  Yebeen Ysabelle Boo, Otto-Emil Jutila, Meghan A. Cupp, Logan Manikam, Sung-Il Cho
  Aging Clinical and Experimental Research.2021; 33(9): 2573.     CrossRef
• Examining the effects of multiple chronic conditions on cognitive decline and potential moderators among older Koreans: Findings from the Korean Longitudinal Study of Ageing 2006–2016
  Yura Lee, Chi C. Cho
  Archives of Gerontology and Geriatrics.2021; 95: 104424.     CrossRef
• Cumulative Exposure to Metabolic Syndrome Components and the Risk of Dementia: A Nationwide Population-Based Study
  Yunjung Cho, Kyungdo Han, Da Hye Kim, Yong-Moon Park, Kun-Ho Yoon, Mee Kyoung Kim, Seung-Hwan Lee
  Endocrinology and Metabolism.2021; 36(2): 424.     CrossRef
• Cardiovascular risks of periodontitis and oral hygiene indicators in patients with diabetes mellitus
  Tae-Jin Song, Jimin Jeon, Jinkwon Kim
  Diabetes & Metabolism.2021; 47(6): 101252.     CrossRef
• Association Between Diabetic Retinopathy and Cognitive Impairment: A Systematic Review and Meta-Analysis
  Dihe Cheng, Xue Zhao, Shuo Yang, Guixia Wang, Guang Ning
  Frontiers in Aging Neuroscience.2021;[Epub]     CrossRef
• Improving Cognition with Nutraceuticals Targeting TGF-β1 Signaling
  Margherita Grasso, Giuseppe Caruso, Justyna Godos, Angela Bonaccorso, Claudia Carbone, Sabrina Castellano, Walter Currenti, Giuseppe Grosso, Teresa Musumeci, Filippo Caraci
  Antioxidants.2021; 10(7): 1075.     CrossRef
• The risk of Alzheimer’s disease according to dynamic changes in metabolic health and obesity: a nationwide population-based cohort study
  Yun Kyung Cho, Jiwoo Lee, Hwi Seung Kim, Joong-Yeol Park, Woo Je Lee, Ye-Jee Kim, Chang Hee Jung
  Aging.2021; 13(13): 16974.     CrossRef
• Letter: Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study (Diabetes Metab J 2020;44:125–33)
  Jin Hwa Kim
  Diabetes & Metabolism Journal.2020; 44(2): 356.     CrossRef
• The Interplay between Diabetes and Alzheimer’s Disease—In the Hunt for Biomarkers
  Adriana Kubis-Kubiak, Aleksandra Dyba, Agnieszka Piwowar
  International Journal of Molecular Sciences.2020; 21(8): 2744.     CrossRef
• Association between cytomegalovirus end-organ diseases and moderate-to-severe dementia: a population-based cohort study
  Kyoung Hwa Lee, Da Eun Kwon, Kyung Do Han, Yeonju La, Sang Hoon Han
  BMC Neurology.2020;[Epub]     CrossRef

The link of diabetes with co-occurring disorders in the brain involves complex and multifactorial pathways. Genetically engineered rodents that express familial Alzheimer's disease-associated mutant forms of amyloid precursor protein and presenilin 1 (PSEN1) genes provided invaluable insights into the mechanisms and consequences of amyloid deposition in the brain. Adding diabetes factors (obesity, insulin impairment) to these animal models to predict success in translation to clinic have proven useful at some extent only. Here, we focus on contributing factors to diabetic brain injury with the aim of identifying appropriate animal models that can be used to mechanistically dissect the pathophysiology of diabetes-associated cognitive dysfunction and how diabetes medications may influence the development and progression of cognitive decline in humans with diabetes.

Citations

Citations to this article as recorded by  

• The association between renal accumulation of pancreatic amyloid-forming amylin and renal hypoxia
  Nirmal Verma, Florin Despa
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• New insights toward molecular and nanotechnological approaches to antidiabetic agents for Alzheimer’s disease
  Sweta Priyadarshini Pradhan, Pratap Kumar Sahu, Anindita Behera
  Molecular and Cellular Biochemistry.2023; 478(12): 2739.     CrossRef
• Nicotinamide Prevents Diabetic Brain Inflammation via NAD+-Dependent Deacetylation Mechanisms
  Jeimy Katherine Torres-Méndez, Julia Niño-Narvión, Patricia Martinez-Santos, Elena María Goretti Diarte-Añazco, Karen Alejandra Méndez-Lara, Tania Vázquez del Olmo, Noemi Rotllan, Maria Teresa Julián, Núria Alonso, Didac Mauricio, Mercedes Camacho, Juan P
  Nutrients.2023; 15(14): 3083.     CrossRef
• Ipriflavone as a non‐steroidal glucocorticoid receptor antagonist ameliorates diabetic cognitive impairment in mice
  Ruifang Nie, Jian Lu, Rui Xu, Juanzhen Yang, Xingyi Shen, Xingnan Ouyang, Danyang Zhu, Yujie Huang, Tong Zhao, Xuejian Zhao, Yin Lu, Minyi Qian, Jiaying Wang, Xu Shen
  Aging Cell.2022;[Epub]     CrossRef
• Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study
  Geert Jan Biessels, Chloë Verhagen, Jolien Janssen, Esther van den Berg, Gudrun Wallenstein, Bernard Zinman, Mark A. Espeland, Odd Erik Johansen
  Diabetologia.2021; 64(6): 1235.     CrossRef
• The Association Between Second-Line Oral Antihyperglycemic Medication on Types of Dementia in Type 2 Diabetes: A Nationwide Real-World Longitudinal Study
  Won Jun Kim, Jung Hyun Noh, Kyungdo Han, Cheol-Young Park
  Journal of Alzheimer's Disease.2021; 81(3): 1263.     CrossRef
• The role of traditional Chinese medicine in the treatment of cognitive dysfunction in type 2 diabetes
  Jinni Meng, Yafei Zhu, Huixia Ma, Xiaobo Wang, Qipeng Zhao
  Journal of Ethnopharmacology.2021; 280: 114464.     CrossRef
• Letter: Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study (Diabetes Metab J 2020;44:125–33)
  Jin Hwa Kim
  Diabetes & Metabolism Journal.2020; 44(2): 356.     CrossRef
• Diabetes and dementia – the two faces of Janus
  Athanasia Papazafiropoulou, Chris Koros, Andreas Melidonis , Stavros Antonopoulos
  Archives of Medical Science – Atherosclerotic Diseases.2020; 5(1): 186.     CrossRef

Mitochondrial function is crucial for the maintenance of cellular homeostasis under physiological and stress conditions. Thus, chronic exposure to environmental chemicals that affect mitochondrial function can have harmful effects on humans. We argue that the concept of hormesis should be revisited to explain the non-linear responses to mitochondrial toxins at a low-dose range and develop practical methods to protect humans from the negative effects of mitochondrial toxins. Of the most concern to humans are lipophilic chemical mixtures and heavy metals, owing to their physical properties. Even though these chemicals tend to demonstrate no safe level in humans, a non-linear dose-response has been also observed. Stress response activation, i.e., hormesis, can explain this non-linearity. Recently, hormesis has reemerged as a unifying concept because diverse stressors can induce similar stress responses. Besides potentially harmful environmental chemicals, healthy lifestyle interventions such as exercise, calorie restriction (especially glucose), cognitive stimulation, and phytochemical intake also activate stress responses. This conceptual link can lead to the development of practical methods that counterbalance the harm of mitochondrial toxins. Unlike chemical hormesis with its safety issues, the activation of stress responses via lifestyle modification can be safely used to combat the negative effects of mitochondrial toxins.

Citations

Citations to this article as recorded by  

• Polyethylene terephthalate (PET) micro- and nanoplastic particles affect the mitochondrial efficiency of human brain vascular pericytes without inducing oxidative stress
  Sean M. Gettings, William Timbury, Anna Dmochowska, Riddhi Sharma, Rebecca McGonigle, Lewis E. MacKenzie, Guillaume Miquelard-Garnier, Nora Bourbia
  NanoImpact.2024; 34: 100508.     CrossRef
• Rules of Heliogeomagnetics Diversely Coordinating Biological Rhythms and Promoting Human Health
  Kuniaki Otsuka, Germaine Cornelissen, Andi Weydahl, Denis Gubin, Larry A. Beaty, Masatoshi Murase
  Applied Sciences.2023; 13(2): 951.     CrossRef
• Can lipophilic pollutants in adipose tissue explain weight change‐related risk in type 2 diabetes mellitus?
  Duk‐Hee Lee, In‐Kyu Lee
  Journal of Diabetes Investigation.2023; 14(4): 528.     CrossRef
• Hormetic Effects of Cerium, Lanthanum and Their Combination at Sub-micromolar Concentrations in Sea Urchin Sperm
  Giovanni Pagano, Antonios Apostolos Brouziotis, Daniel Lyons, Ivana Čarapar, Rahime Oral, Serkan Tez, Philippe J. Thomas, Franca Tommasi, Giovanni Libralato, Marco Guida, Marco Trifuoggi
  Bulletin of Environmental Contamination and Toxicology.2023;[Epub]     CrossRef
• Mitochondria: It is all about energy
  Amaloha Casanova, Anne Wevers, Santiago Navarro-Ledesma, Leo Pruimboom
  Frontiers in Physiology.2023;[Epub]     CrossRef
• Type 2 Diabetes Induced by Changes in Proteomic Profiling of Zebrafish Chronically Exposed to a Mixture of Organochlorine Pesticides at Low Concentrations
  Yan Gao, Hyojin Lee, Sangkyu Lee, Ki-Tae Kim
  International Journal of Environmental Research and Public Health.2022; 19(9): 4991.     CrossRef
• Effect of Low-Dose Persistent Organic Pollutants on Mitochondrial Function: Human and in Vitro Evidence
  Se-A Kim, Hoyul Lee, Sung-Mi Park, Mi-Jin Kim, Yu-Mi Lee, Young-Ran Yoon, Hyun-Kyung Lee, Hyo-Bang Moon, In-Kyu Lee, Duk-Hee Lee
  Diabetes & Metabolism Journal.2022; 46(4): 592.     CrossRef
• Can Environmental Pollutants Be a Factor Linking Obesity and COVID-19?
  Duk-Hee Lee
  Journal of Korean Medical Science.2021;[Epub]     CrossRef
• Intensive weight loss and cognition: The dynamics of persistent organic pollutants in adipose tissue can explain the unexpected results from the Action for Health in Diabetes (Look AHEAD) study
  Yu‐Mi Lee, Sun‐Hee Park, Duk‐Hee Lee
  Alzheimer's & Dementia.2020; 16(4): 696.     CrossRef
• Lipophilic Environmental Chemical Mixtures Released During Weight‐Loss: The Need to Consider Dynamics
  Duk‐Hee Lee, David R Jacobs, Lars Lind, P. Monica Lind
  BioEssays.2020;[Epub]     CrossRef
• Environmental toxicology and ecotoxicology: How clean is clean? Rethinking dose-response analysis
  Evgenios Agathokleous, Edward J. Calabrese
  Science of The Total Environment.2020; 746: 138769.     CrossRef

Citations

Citations to this article as recorded by  

• Potential risk factors for mild cognitive impairment among patients with type 2 diabetes experiencing hypoglycemia
  Ruonan Gao, Menglan Zhan, Sujie Ke, Kejun Wu, Guanlian He, Liqin Qi, Xiaoying Liu, Xiaohong Liu, Lijing Wang, Libin Liu
  Diabetes Research and Clinical Practice.2024; 207: 111036.     CrossRef
• Association of hypoglycemic events with cognitive impairment in patients with type 2 diabetes mellitus: Protocol for a dose-response meta-analysis
  Min Ye, Ai Hong Yuan, Qi Qi Yang, Qun Wei Li, Fei Yue Li, Yan Wei, Muhammad Shahzad Aslam
  PLOS ONE.2024; 19(2): e0296662.     CrossRef
• Hypoglycaemia and the risk of dementia: a population-based cohort study using exposure density sampling
  Wajd Alkabbani, Colleen J Maxwell, Ruth Ann Marrie, Suzanne L Tyas, Iliana C Lega, John-Michael Gamble
  International Journal of Epidemiology.2023; 52(3): 908.     CrossRef
• Type 2 diabetes mellitus and cognitive function: understanding the connections
  Lisa Dao, Sarah Choi, Matthew Freeby
  Current Opinion in Endocrinology, Diabetes & Obesity.2023; 30(1): 7.     CrossRef
• Associations of Mid- and Late-Life Severe Hypoglycemic Episodes With Incident Dementia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study
  Wajd Alkabbani, Colleen J. Maxwell, Ruth Ann Marrie, Suzanne L. Tyas, Iliana C. Lega, John-Michael Gamble
  Diabetes Care.2023; 46(2): 331.     CrossRef
• Nocturnal hypoglycemia is underdiagnosed in older people with insulin‐treated type 2 diabetes: The HYPOAGE observational study
  Anne‐Sophie Boureau, Béatrice Guyomarch, Pierre Gourdy, Ingrid Allix, Cédric Annweiler, Nathalie Cervantes, Guillaume Chapelet, Isabelle Delabrière, Sophie Guyonnet, Rachel Litke, Marc Paccalin, Alfred Penfornis, Pierre‐Jean Saulnier, Matthieu Wargny, Sam
  Journal of the American Geriatrics Society.2023; 71(7): 2107.     CrossRef
• Dementia in Diabetes: The Role of Hypoglycemia
  Khaled Hameed Husain, Saud Faisal Sarhan, Haya Khaled Ali Abdulla AlKhalifa, Asal Buhasan, Abu Saleh Md Moin, Alexandra E. Butler
  International Journal of Molecular Sciences.2023; 24(12): 9846.     CrossRef
• Association Between Trajectory of Severe Hypoglycemia and Dementia in Patients With Type 2 Diabetes: A Population-based Study
  Chung-Yi Li, Chia-Lun Kuo, Ya-Hui Chang, Chin-Li Lu, Santi Martini, Wen-Hsuan Hou
  Journal of Epidemiology.2022; 32(9): 423.     CrossRef
• Severe Hypoglycemia Increases Dementia Risk and Related Mortality: A Nationwide, Population-based Cohort Study
  Eugene Han, Kyung-do Han, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Seung-Hyun Ko, Yong-ho Lee
  The Journal of Clinical Endocrinology & Metabolism.2022; 107(5): e1976.     CrossRef
• Association between hypoglycemia and dementia in patients with diabetes: a systematic review and meta-analysis of 1.4 million patients
  Lifen Huang, Manlian Zhu, Jie Ji
  Diabetology & Metabolic Syndrome.2022;[Epub]     CrossRef
• Potential Roles of Glucagon-Like Peptide-1 and Its Analogues in Dementia Targeting Impaired Insulin Secretion and Neurodegeneration
  Sidharth Mehan, Sonalika Bhalla, Ehraz Mehmood Siddiqui, Nidhi Sharma, Ambika Shandilya, Andleeb Khan
  Degenerative Neurological and Neuromuscular Disease.2022; Volume 12: 31.     CrossRef
• Immortal time bias for life-long conditions in retrospective observational studies using electronic health records
  Freya Tyrer, Krishnan Bhaskaran, Mark J. Rutherford
  BMC Medical Research Methodology.2022;[Epub]     CrossRef
• Glucose-lowering drugs, cognition, and dementia: The clinical evidence
  Che-Yuan Wu, Lila Shapiro, Michael Ouk, Bradley J. MacIntosh, Sandra E. Black, Baiju R. Shah, Walter Swardfager
  Neuroscience & Biobehavioral Reviews.2022; 137: 104654.     CrossRef
• Switching insulin degludec to insulin glulisine improved nocturnal hypoglycemia and ventricular arrythmia in an elderly type 1 diabetes patient with chronic heart failure: A case report
  Yuriko Hajika, Yuji Kawaguchi, Takako Tanaka, Kenji Hamazaki, Yasuro Kumeda
  Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics.2022; 59(2): 237.     CrossRef
• Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline
  Hanan Ehtewish, Abdelilah Arredouani, Omar El-Agnaf
  International Journal of Molecular Sciences.2022; 23(11): 6144.     CrossRef
• Amyloid $$upbeta$$ (1–42) peptide impairs mitochondrial respiration in primary human brain microvascular endothelial cells: impact of dysglycemia and pre-senescence
  Siva S. V. P. Sakamuri, Venkata N. Sure, Xiaoying Wang, Gregory Bix, Vivian A. Fonseca, Ricardo Mostany, Prasad V. G. Katakam
  GeroScience.2022; 44(6): 2721.     CrossRef
• Mechanistic Role of Jak3 in Obesity-Associated Cognitive Impairments
  Premranjan Kumar, Jayshree Mishra, Narendra Kumar
  Nutrients.2022; 14(18): 3715.     CrossRef
• Assessing real-world effectiveness of therapies: what is the impact of incretin-based treatments on hospital use for patients with type 2 diabetes?
  Clémence Bussiere, Pauline Chauvin, Jean-Michel Josselin, Christine Sevilla-Dedieu
  Health Economics Review.2022;[Epub]     CrossRef
• Fasting Glucose Variability and the Risk of Dementia in Individuals with Diabetes: A Nationwide Cohort Study
  Da Young Lee, Jaeyoung Kim, Sanghyun Park, So Young Park, Ji Hee Yu, Ji A Seo, Nam Hoon Kim, Hye Jin Yoo, Sin Gon Kim, Kyung Mook Choi, Sei Hyun Baik, Kyungdo Han, Nan Hee Kim
  Diabetes & Metabolism Journal.2022; 46(6): 923.     CrossRef
• Meta-Analysis: Association Between Hypoglycemia and Serious Adverse Events in Older Patients Treated With Glucose-Lowering Agents
  Katharina Mattishent, Yoon K. Loke
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Hypoglycemia, Vascular Disease and Cognitive Dysfunction in Diabetes: Insights from Text Mining-Based Reconstruction and Bioinformatics Analysis of the Gene Networks
  Olga V. Saik, Vadim V. Klimontov
  International Journal of Molecular Sciences.2021; 22(22): 12419.     CrossRef
• Muscle strength, an independent determinant of glycemic control in older adults with long-standing type 2 diabetes: a prospective cohort study
  Bo Kyung Koo, Seoil Moon, Min Kyong Moon
  BMC Geriatrics.2021;[Epub]     CrossRef
• Optimal Type 2 Diabetes Mellitus Management and Active Ageing
  Alessia Maria Calabrese, Valeria Calsolaro, Sara Rogani, Chukwuma Okoye, Nadia Caraccio, Fabio Monzani
  Endocrines.2021; 2(4): 523.     CrossRef
• Response: Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study (Diabetes Metab J 2020;44:125–33)
  Seung Jin Han
  Diabetes & Metabolism Journal.2020; 44(2): 360.     CrossRef
• Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study
  Francesco Zaccardi, Suping Ling, Claire Lawson, Melanie J. Davies, Kamlesh Khunti
  Diabetologia.2020; 63(10): 2129.     CrossRef
• Letter: Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study (Diabetes Metab J 2020;44:125–33)
  Jin Hwa Kim
  Diabetes & Metabolism Journal.2020; 44(2): 356.     CrossRef
• Low‐glucose‐sensitive TRPC6 dysfunction drives hypoglycemia‐induced cognitive impairment in diabetes
  Chengkang He, Peng Gao, Yuanting Cui, Qiang Li, Yingsha Li, Zongshi Lu, Huan Ma, Yu Zhao, Li Li, Fang Sun, Xiaowei Chen, Hongbo Jia, Daoyan Liu, Gangyi Yang, Hongting Zheng, Zhiming Zhu
  Clinical and Translational Medicine.2020;[Epub]     CrossRef
• Hypoglycaemia and Cardiovascular Disease Risk in Patients with Diabetes
  Niki Katsiki, Kalliopi Kotsa, Anca P. Stoian, Dimitri P. Mikhailidis
  Current Pharmaceutical Design.2020; 26(43): 5637.     CrossRef